Lawyers began selecting jurors to hear a lawsuit accusing healthcare giant Johnson & Johnson of liability for patient injuries allegedly caused by the company's transvaginal mesh implants.
MASSDEVICE ON CALL — A bellwether trial against Johnson & Johnson (NYSE:JNJ) began this month with lawyers beginning to select jurors to hear a lawsuit accusing the healthcare giant of liability patient injuries allegedly caused by the company's transvaginal mesh implants.
Plaintiff Linda Gross claims that J&J subsidiary Ethicon's Prolift implant left her with severe chronic pain that prevents her from working or even sitting.
Decisions made in this trial, which is taking place in New Jersey and expected to take about 2 months, may trickle down to similar lawsuits against C.R. Bard (NYSE:BCR), Endo Pharmaceuticals Holdings (NSDQ:ENDP) and Boston Scientific (NYSE:BSX).
Courts in West Virgina are slated in February to begin hearing cases against makers of transvaginal mesh implants, starting with a lawsuit against Bard.
J&J's Prolift device has been at the center of controversy over whether or not J&J marketed the device to doctors and patients without proper FDA approval.
A federal jury in Texas clears Johnson & Johnson's DePuy Pinnacle hip implant in the 1st...
Edwards Lifesciences reports 3rd-quarter sales and earnings growth in excess of 20% and raises its...
A federal jury in Texas reportedly clears Johnson & Johnson's DePuy Pinnacle hip implant in the...
Federal auditors say the FDA needs to ramp up its cybersecurity efforts in order to deter hackers.